Analysis of impact of type 1 diabetes on colorectal cancer by using two-sample Mendelian randomization

doi:10.3969/j.issn.1674-8115.2024.06.011

Abstract

Abstract:

Objective ·To investigate the potential causal relationship between type 1 diabetes and colorectal cancer by using Mendelian randomization (MR). Methods ·Two-sample bidirectional MR was used to investigate the causal relationship between type 1 diabetes and colorectal cancer. All research data were collected from the IEU Open GWAS Project database. The dataset of type 1 diabetes included 9 266 cases and 15 574 controls, with correlation analysis in 12 783 129 single nucleotide polymorphisms (SNPs); the dataset of colorectal cancer included 5 657 cases and 372 016 controls, with correlation analysis in 29 999 696 SNPs. The instrumental variables SNPs were screened. The results derived from the inverse-variance weighted (IVW) method were used as the main indicator of effect. The results derived from other four methods, namely MR-Egger regression, weighted median, simple mode, and weighted mode, were used as reference. Sensitivity was analyzed with the leave-one-out method. Heterogeneity was analyzed with Cochran's Q test by using both IVW and MR-Egger methods. Pleiotropy was analyzed with MR-pleiotropy function, and Steiger test was used for directional research. The colocation analysis was used to find out whether the causal relationship between type 1 diabetes and colorectal cancer was caused by the same SNP. The genetic correlation between 2 diseases was analyzed by using the linkage disequilibrium score regression (LDSC). All tests were analyzed by using R language software (version 4.3.1). Results ·After being screened, a total of 33 instrumental variables (SNPs) were used. The heterogeneity test results showed that there was heterogeneity among the SNPs (IVW and MR-Egger: P<0.05), so the effect evaluation was based on the results of the random effect model. MR analysis showed that type 1 diabetes had a significant causal effect on colorectal cancer (P<0.05) by using IVW, MR-Egger, weighted median and weighted mode. Sensitivity analysis showed that the results were stable. Pleiotropy was not detected in pleiotropy test (P>0.05). Steiger test showed that the effect of type 1 diabetes on colorectal cancer was not interfered with by the reverse effect. Reverse MR analysis showed no causal effect of colorectal cancer on type 1 diabetes (P>0.05). The results of colocalization analysis showed that the probability of H₄ hypothesis was 45.7%, and the causal relationship between the 2 diseases was not caused by the same SNP in the gene sequences. LDSC analysis demonstrated that there was no genetic correlation between the two diseases. Conclusion ·Type 1 diabetes may promote colorectal cancer, but colorectal cancer has no effect on type 1 diabetes.

Key words: colorectal cancer, type 1 diabetes, Mendelian randomization

CLC Number:

R735.3

YU Yang, MENG Dan, QIU Yiwen, YUAN Jian, ZHU Yingjie. Analysis of impact of type 1 diabetes on colorectal cancer by using two-sample Mendelian randomization[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(6): 755-761.

Figures/Tables 6

TrendMD

References 27

1	URBANO F, FARELLA I, BRUNETTI G, et al. Pediatric type 1 diabetes: mechanisms and impact of technologies on comorbidities and life expectancy[J]. Int J Mol Sci, 2023, 24(15): 11980.
2	罗飞宏. 儿童1型糖尿病的诊治与展望[J]. 临床儿科杂志, 2022, 40(5): 321-327.
	LUO F H. Diagnosis, treatment and future of childhood type 1 diabetes mellitus[J]. Journal of Clinical Pediatrics, 2022, 40(5): 321-327.
3	YANG Y, HAN Z H, LI X, et al. Epidemiology and risk factors of colorectal cancer in China[J]. Chin J Cancer Res, 2020, 32(6): 729-741.
4	孟令华, 常湛, 王丽慧, 等. 结直肠癌与2型糖尿病的相关性及临床特征分析[J]. 现代中西医结合杂志, 2016, 25(9): 999-1000.
	MENG L H, CHANG K, WANG L H, et al. Correlation and clinical characteristics of colorectal cancer and type 2 diabetes[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2016, 25(9): 999-1000.
5	SKRIVANKOVA V W, RICHMOND R C, WOOLF B A R, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement[J]. JAMA, 2021, 326(16): 1614-1621.
6	FORGETTA V, MANOUSAKI D, ISTOMINE R, et al. Rare genetic variants of large effect influence risk of type 1 diabetes[J]. Diabetes, 2020, 69(4): 784-795.
7	SEKULA P, DEL GRECO M F, PATTARO C, et al. Mendelian randomization as an approach to assess causality using observational data[J]. J Am Soc Nephrol, 2016, 27(11): 3253-3265.
8	LIU N Y, WANG G, LIU C, et al. Non-alcoholic fatty liver disease and complications in type 1 and type 2 diabetes: a Mendelian randomization study[J]. Diabetes Obes Metab, 2023, 25(2): 365-376.
9	LIU Z R, WANG H C, YANG Z K, et al. Causal associations between type 1 diabetes mellitus and cardiovascular diseases: a Mendelian randomization study[J]. Cardiovasc Diabetol, 2023, 22(1): 236.
10	KAMAT M A, BLACKSHAW J A, YOUNG R, et al. PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations[J]. Bioinformatics, 2019, 35(22): 4851-4853.
11	BRION M J A, SHAKHBAZOV K, VISSCHER P M. Calculating statistical power in Mendelian randomization studies[J]. Int J Epidemiol, 2013, 42(5): 1497-1501.
12	BOWDEN J, DEL GRECO M F, MINELLI C, et al. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization[J]. Stat Med, 2017, 36(11): 1783-1802.
13	BOWDEN J, DAVEY SMITH G, BURGESS S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression[J]. Int J Epidemiol, 2015, 44(2): 512-525.
14	BOWDEN J, DAVEY SMITH G, HAYCOCK P C, et al. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator[J]. Genet Epidemiol, 2016, 40(4): 304-314.
15	HARTWIG F P, DAVEY SMITH G, BOWDEN J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption[J]. Int J Epidemiol, 2017, 46(6): 1985-1998.
16	HEMANI G, TILLING K, DAVEY SMITH G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data[J]. PLoS Genet, 2017, 13(11): e1007081.
17	YUN Z J, GUO Z W, LI X, et al. Genetically predicted 486 blood metabolites in relation to risk of colorectal cancer: a Mendelian randomization study[J]. Cancer Med, 2023, 12(12): 13784-13799.
18	BULIK-SULLIVAN B K, LOH P R, FINUCANE H K, et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies[J]. Nat Genet, 2015, 47(3): 291-295.
19	CHEN C, WANG P, ZHANG R D, et al. Mendelian randomization as a tool to gain insights into the mosaic causes of autoimmune diseases[J]. Autoimmun Rev, 2022, 21(12): 103210.
20	牛相英. 2型糖尿病与结直肠癌临床病理特征的研究[D]. 银川: 宁夏医科大学, 2020.
	NIU X Y. Study on the relationship between type 2 diabetes mellitus and colorectal cancer in clinicopathological characteristics[D]. Yinchuan: Ningxia Medical University, 2020.
21	杨千洪, 雷新键, 李峰, 等. 结直肠癌与2型糖尿病的相关性及临床特征分析[J]. 中国卫生标准管理, 2022, 13(24): 80-83.
	YANG Q H, LEI X J, LI F, et al. Correlation and clinical characteristics of colorectal cancer onset and type 2 diabetes mellitus[J]. China Health Standard Management, 2022, 13(24): 80-83.
22	张欣怡, 林翔, 刘希樵, 等. 基于网络药理学和分子对接探究葛根芩连汤“异病同治”结直肠癌和2型糖尿病作用机制[J]. 中国中医药信息杂志, 2022, 29(7): 24-32.
	ZHANG X Y, LIN X, LIU X Q, et al. Study on mechanism of treating different diseases with same method of Gegen Qinlian Decoction in treating colorectal cancer and type 2 diabetes mellitus based on network pharmacology and molecular docking[J]. Chinese Journal of Information on Traditional Chinese Medicine, 2022, 29(7): 24-32.
23	JOH H K, LEE D H, HUR J, et al. Simple sugar and sugar-sweetened beverage intake during adolescence and risk of colorectal cancer precursors[J]. Gastroenterology, 2021, 161(1): 128-142.e20.
24	HUR J, OTEGBEYE E, JOH H K, et al. Sugar-sweetened beverage intake in adulthood and adolescence and risk of early-onset colorectal cancer among women[J]. Gut, 2021, 70(12): 2330-2336.
25	LAMB M M, FREDERIKSEN B, SEIFERT J A, et al. Sugar intake is associated with progression from islet autoimmunity to type 1 diabetes: the Diabetes Autoimmunity Study in the Young[J]. Diabetologia, 2015, 58(9): 2027-2034.
26	柳健, 廖斐, 董卫国. 早发性结直肠癌相关危险因素的研究进展[J]. 医学研究杂志, 2022, 51(5): 26-29.
	LIU J, LIAO F, DONG W G, et al. Research progress on risk factors related to early-onset colorectal cancer[J]. Journal of Medical Research, 2022, 51(5): 26-29.
27	GONZALEZ-GRONOW M, PIZZO S V. Physiological roles of the autoantibodies to the 78-kilodalton glucose-regulated protein (GRP78) in cancer and autoimmune diseases[J]. Biomedicines, 2022, 10(6): 1222.

Exposure	Outcome	MR method	P value	OR (95%CI)
Type 1 diabetes	Colorectal cancer	IVW	0.003 4	1.000 7 (1.000 2‒1.001 1)
		MR-Egger	0.001 3	1.001 1 (1.000 5‒1.001 8)
		Weighted median	3.39×10^-5	1.001 0 (1.000 5‒1.001 4)
		Simple mode	0.671 9	1.000 3 (0.998 8‒1.001 9)
		Weighted mode	0.000 1	1.001 0 (1.000 6‒1.001 4)

Exposure	Outcome	MR method	P value	OR (95%CI)
Type 1 diabetes	Colorectal cancer	IVW	0.003 4	1.000 7 (1.000 2‒1.001 1)
		MR-Egger	0.001 3	1.001 1 (1.000 5‒1.001 8)
		Weighted median	3.39×10^-5	1.001 0 (1.000 5‒1.001 4)
		Simple mode	0.671 9	1.000 3 (0.998 8‒1.001 9)
		Weighted mode	0.000 1	1.001 0 (1.000 6‒1.001 4)

Exposure	Outcome	MR method	P value	OR (95%CI)
Colorectal cancer	Type 1 diabetes	IVW	0.373 2	0.013 8 (1.12×10^-6‒171.093 6)
		MR-Egger	0.643 6	0.000 3 (3.23×10^-18‒2.96×10^-10)
		Weighted median	0.273 9	0.000 8 (2.34×10^-9‒279.941 3)
		Simple mode	0.247 1	3.36×10^-6 (1.82×10^-14‒745.124 1)
		Weighted mode	0.266 8	4.42×10^-5 (4.18×10^-12‒426.783 2)

Exposure	Outcome	MR method	P value	OR (95%CI)
Colorectal cancer	Type 1 diabetes	IVW	0.373 2	0.013 8 (1.12×10^-6‒171.093 6)
		MR-Egger	0.643 6	0.000 3 (3.23×10^-18‒2.96×10^-10)
		Weighted median	0.273 9	0.000 8 (2.34×10^-9‒279.941 3)
		Simple mode	0.247 1	3.36×10^-6 (1.82×10^-14‒745.124 1)
		Weighted mode	0.266 8	4.42×10^-5 (4.18×10^-12‒426.783 2)

[1]	JIANG Yi, HUANG Chenhao, LI Zhiliang, WU Junwei, ZHAO Ren, ZHANG Tao. Effect of preoperative chemotherapy combined with immunotherapy in a colorectal cancer patient with KRAS mutation [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(9): 1256-1260.
[2]	LI Long, ZHAO Xia, JIN Shan, LI Zeying, LÜ Fuqiang, PANG Lijuan, LIU Kejian. Deciphering the protective role of AZGP1 in heart failure through Mendelian randomization [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(8): 1035-1045.
[3]	YAN Junhao, GUO Xiaolei, LUO Zhaofeng, TANG Jian, WANG Zheng. Mendelian randomization analysis of causal relationship between celiac disease and autoimmune thyroid disease [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(6): 766-773.
[4]	XU Ling, HUANGFU Yuchan, SHEN Lisong, MA Yanhui. Causal association between plasma phosphatidylethanolamine and risk of colorectal adenocarcinoma: a two-sample Mendelian randomization study [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(5): 605-613.
[5]	ZHANG Huihua, GAN Jing, HOU Miaomiao, LU Na. Bidirectional Mendelian randomization study of the relationship between brain imaging-derived phenotypes and obstructive sleep apnea [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(4): 468-475.
[6]	CHEN Jiaying, CHU Yimin, PENG Haixia. Study on prediction model and influencing factors of progression-free survival in colorectal cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(3): 324-334.
[7]	LIANG Lebin, CHEN Huifang, LAI Shujing, GU liang, SU Bing. Analysis of epigenetic characteristics in colonic tumors of Apc^min/+via spatial ATAC-seq technology [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(10): 1261-1270.
[8]	ZHANG Yingying, ZHANG Junyao, SONG Jiwei, WANG Shengjie, YAO Junyan. Two-sample Mendelian randomization study on the causal association between air pollution and Alzheimer′s disease [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(1): 87-94.
[9]	QIAN Liheng, WEN Kailing, LIAO Yingna, LI Shuxin, NIE Huizhen. Study on the effect and mechanism of sorting nexin 1 on inhibiting the proliferation and migration of colorectal cancer cells [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(9): 1124-1135.
[10]	FENG Xujiao, LIU Jianyue, QI Yangyang, SUN Jing, SHEN Lei. Phenotype and function of NK cell in colorectal cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(6): 713-722.
[11]	LUO Chen, SHEN Ling, WANG Chuanwei, GU Jiani, WANG Jin, ZHAO Li, HUANG Shuai. Current status and influencing factors of early mobilization of patients undergoing laparoscopic radical resection of colorectal cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(9): 1201-1210.
[12]	PENG Tian, XU Leiming. Crosstalk between epigenetic modification and circRNA in colorectal cancer: recent advances [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(2): 237-243.
[13]	TU Juanjuan, JIN Zhiming. Research progress of immune checkpoint inhibitors in the treatment of metastatic colorectal cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(2): 250-255.
[14]	GAO Xiong, ZHANG Qiuxia, YANG Miaomiao, LUO Wei, WANG Yuegang, XIU Jiancheng. Causal relationship between atrial fibrillation and cognitive impairment: a Mendelian randomization study [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(11): 1359-1365.
[15]	TAI Rui, FANG Fang, MAO Jingjue, ZHOU Xia. Analysis of influencing factors of adaptation level in patients with permanent enterostomy [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(11): 1423-1429.